S. Lanes

Pharmacoepidemiology and Drug Safety · 2004–2006

A researcher in the Science corpus: 2 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Whom S. Lanes trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. S. Evans

Papers from S. Lanes's perspective

Ordered by how strongly the researchers S. Lanes trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports (Pharmacoepidemiology and Drug Safety)
  2. A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions (Pharmacoepidemiology and Drug Safety)
  3. Statistical aspects of the analysis of data from retrospective studies of disease.
  4. Empirical bayes screening for multi-item associations (Knowledge Discovery and Data Mining)
  5. Use of Screening Algorithms and Computer Systems to Efficiently Signal Higher-Than-Expected Combinations of Drugs and Events in the US FDA’s Spontaneous Reports Database (Drug Safety)
  6. Non‐inferiority trials: design concepts and issues – the encounters of academic consultants in statistics (Statistics in Medicine)
  7. CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials (British medical journal)
  8. WHO antenatal care randomised trial for the evaluation of a new model of routine antenatal care. (The Lancet)
  9. Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement. (Journal of the American Medical Association (JAMA))
  10. Better Reporting of Harms in Randomized Trials: An Extension of the CONSORT Statement (Annals of Internal Medicine)

Their papers